##
##
|nts||||||
|---|---|---|---|---|---|
|1.|Strategic Report||||Page|
||o|Highlights
ofthe year|||3|
||o|Purpose and Values|||6|
||o|Structure, Governance|and Management||6|
||o|Report ofthe chair|||9|
||o|Chief Executives Report|||10|
||o|Our Ambitions
2023-2028|||11|
||o|Risk Management
and|Internal|Control|12|
||o|Financial Review|||13|
|2.|Directors Report|||||
||o|Reserves Policy|||15|
||o|Volunteers|||15|
||o|Fundraising|||15|
||o|Executive remuneration|||16|
||o|Investment
policy and objectives|||16|
||o|Our impact on the environment|||17|
||o|Tax status|||17|
||o|Directors responsibilities|statement||17|
||o|Statement ofdisclosure|to auditor||18|
|3.|Independent
auditor's
report||||19|
|4.|Financial
Statements||||23|
|5.|Notes|to the Financial Statements|||26|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Clinical Services||Income Generntion||||
|---|---|---|---|---|---|
|Commi tree|Finance
Committee|Committee|Governance
Comntittee|Remuneration|Cotnmittee|
|Dr S Hawkins
(Chair)|Mrs S M Godzicz (Chair)|Mr G Piercy (Chair)|Mr D Renwick (Chair)|Mr D W Renwick||
|DR CJ Phillip|Mr A Naylor|Mr D Thomas|DrS Hawkins|DrSHawkins||
|Mrs LJ Stubberfield|Mr AJWhyte|Mrs L Clarke|Mrs S M Godzicz|Mrs S M Godzicz||
|Dr SGupta|Mr D W Renwick||Dr C Philip|Mr G Piercy||
|Mr D W Renwick|DrS Hawkins||Mrs LJ Stubberfield|||
|Mrs D M R Roberts|Mrs S M Bamford||Mr G Piercy|||
##
##
##
##
##
##
##
|Advisers||||||
|---|---|---|---|---|---|
|Solicitors:|Michelmores
LLP||Auditors:|RRL||
||Woodwater
House|||Peat House||
||Pynes
Hill|||Newham
Road||
||Exeter,
EX25WR|||Truro,|TR12DP|
|Investments:|ABDRN||Bankers:|Barclays Bank PLC||
||280 Bishopsgate,|London||14 King Street||
||EX2M 4AG|||Truro,|TR1 2RB|
||RBC Brewin Dolphin|||||
||Vantage
Point|||||
||Woodwater
Park|||||
||Pynes
Hill|||||
||Exeter, EX2 5FD|||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|rformance
is summarised
in the tab|rformance
is summarised
in the tab|le below:|||
|---|---|---|---|---|
|Financial Summary f000s||2022/23
Actual|2022/23
Budget|2021/22
Actual|
|Total Income||12,523.2|13,015.0|11,295.9|
|Expenditure||11,078.9|11,090.7|10,321.1|
|Operating
Result||1,444.3|1,924.3|974.7|
|Gain / (loss) on investments|gL property|-251.0|0.0|29.7|
|Gain /(loss) on disposal of|fixed assets|0.0|0.0|0.0|
|Gain/(Loss) on pension scheme provision|||0.0||
|Surplus / deficit||1,193.2|1,924.3|1,004.4|
##
##
##
|Income Summary f000s|2022/23
Actual|2022/23
Budget|2021/22
Actual|
|---|---|---|---|
|Legacies|4,479.0|5,200.0|3,716.7|
|Donations|465.2|454.7|528.7|
|Fundraising|785.9|811.7|585.1|
|Gross income from Retail|4,593.0|4,421.3|4,024.2|
|Gross income from Lottery|759.4|749.1|703.5|
|Income from clinical contracts|1,102.9|1,102.9|1,060.5|
|Covid 19Grants|0.0|0.0|335.5|
|Investment
income|99.9|116.1|93.6|
|All other income|237.9|159.1|248.1|
|Total Income|12,523.2|13,015.0|11,295.9|
##
|below set|s out the summary
o|fexpenditure
i|ncurred.||
|---|---|---|---|---|
|Expenditure|Summary f000s|2022/23
Actual|2022/23
Budget|2021/22
Actual|
|Retail||3,457.8|3,399.1|3,203.8|
|Lottery||324.2|326.0|294.2|
|Cost ofraising funds||521.3|474.9|419.1|
|Provision ofcare||6,627.5|6,740.6|6,229.3|
|Support costs||148.1|150.0|174.7|
|Total Expenditure||11,078.9|11,090.7|10,321.1|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|For the year ended 31M|arc|h|2023||||||
|---|---|---|---|---|---|---|---|---|
||||||Unrestricted|Restricted|Total|Total|
||||||funds|funds|2023|2022|
|||||Notes|||||
|Income|||||||||
|Donations &legacies|||||4,908,158|36,000|4,944,158|4,245,432|
|Income from Charitable|Activities||||1,102,884||1,102,884|1,060,463|
|Income from Other Trading|||Activities:||||||
|Commercial
trading operations|||||5,352,362||5,352,362|4,727,712|
|Fundraising|||||785,945||785,945|585,128|
|Covid-19 support income||||||||335,473|
|Other income|||||237,934||237,934|248,099|
|Investment
income|||||99,915||99,915|93,559|
|Total Income|||||12,487,198|36,000|12,523,198|11,295,866|
|Expenditure|||||||||
|Expenditure
on raising|funds||||||||
|Commercial
trading activities|||||3,782,000||3,782,000|3,497,975|
|Costs ofgenerating
donations|||and legacies||492,094||492,094|391,124|
|Investment
portfolio fees|||||29,240||29,240|28,009|
|Expenditure
on charitable||activities|||||||
|Provision ofcare|||||6,603,026|24,469|6,627,495|6,229,245|
|Support costs|||||148,091||148,091|174,747|
|Total Expenditure|||||11,054,451|24,469|11,078,920|10,321,100|
|Net (losses)/gains
on investments|||||(251,040)||(251,040)|39,002|
|Net income/(expenditure)|||||1,181,707|11,531|1,193,238|1,013,768|
|Other recognised
gains|and|losses|||||||
|Loss on disposal ofinvestment|||property|||||(9,381)|
|Net movement
in funds|||||1,181,707|11,531|1,193,238|1,004,387|
|Reconciliation offunds:|||||||||
|Fund balances brought
forward|||||9,360,657|729,329|10,089,986|9,085,599|
|Fund balances carried forward||||27,28,29|10,542,364|740,860|11,283,224|10,089,986|
##
##
|As at 31Ma|rch 202|3||||||
|---|---|---|---|---|---|---|---|
|||||The|The|The|The|
|||||Company|Group|Company|Group|
|||||2023|2023|2022|2022|
||||Notes|||||
|Fixed assets||||||||
|Tangible assets|||18,19|4,136,110|4,144,910|4,162,820|4,176,020|
|Intangible
assets|||20|||||
|Investments|||21|4,613,283|4,613,278|4,817,568|4,817,563|
|||||8,749,393|8,758,188|8,980,388|8,993,583|
|Current assets||||||||
|Stock|||22|12,370|85,709|20,979|96,277|
|Debtors|||23|463,067|472,240|751,448|622,295|
|Cash at bank|and in|hand||2,923,888|2,976,245|906,580|1,109,661|
|||||3,399,325|3,534,194|1,679,007|1,828,233|
|Creditors:|amounts|falling due within||||||
|one year|||24|(1,013,484)|(1,009,158)|(614,127)|(731,830)|
|Net current|assets|||2,385,841|2,525,036|1,064,880|1,096,403|
|Total net assets||||11,135,234|11,283,224|10,045,268|10,089,986|
|The funds ofthe charity||||||||
|Restricted funds|||27|740,860|740,860|729,329|729,329|
|Unrestricted|funds||28|10,394,374|10,542,364|9,315,939|9,360,657|
|Total funds||||11,135,234|11,283,224|10,045,268|10,089,986|
##
##
||||Note||2023||2022|
|---|---|---|---|---|---|---|---|
|Cash provided
by||||||||
|operating
activities|||34||2,090,428||1,728,350|
|Cash flows from investing|activities|||||||
|Interest income||||5,020||228||
|Dividends
income||||73,595||52,973||
|Rental income from investment||property||21,300||40,358||
||||||99,915||93,559|
|Purchase oftangible fixed assets||||(276,998)||(147,394)||
|Purchase ofinvestments||||(1,422,911)||(1,993,227)||
|Receipts from sale ofinvestments||||1,376,150||824,662||
|Net cash (outflows)/inflows|from investing|||||||
|activities|||||(323,759)||(1,315,959)|
|Increase in cash equivalents|||||1,866,584||505,950|
|Cash and cash equivalents|at 1April 2022||||1,109,661||603,711|
|Cash and cash equivalents|at31March 2023||||2,976,245||1,109,661|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Donations
and legacies|||
|---|---|---|
||2023|2022|
|Legacies|4,478,984|3,716,722|
|Donations|465,174|528,710|
||4,944,158|4,245,432|
##
|5|Income from charitab|le
activities|||
|---|---|---|---|---|
||||2023|2022|
||Health authority
contract||1,102,884|1,060,463|
|6|Income from trading|activities|||
||Commercial
operations||||
||||2023|2022|
||Gross Income from shops||4,592,962|4,024,184|
||Gross Income from Lottery||759,400|703,528|
||||5,352,362|4,727,712|
||Fundraisi ng||||
||||2023|2022|
||Trusts and grants||82,488|124,746|
||Fundraising
activities||703,457|460,382|
||||785,945|585,128|
|7|Covid-19 support grant income|Covid-19 support grant income|Covid-19 support grant income|Covid-19 support grant income|||
|---|---|---|---|---|---|---|
||||||Group|Group|
||||||2023|2022|
||Grant income||from NHS England|||192,023|
||Job Retention||Scheme grant income|||21,160|
||Local Authority|||grant income||122,290|
|||||||335,473|
|8|Investment|income|||||
||||||Group|Group|
||||||2023|2022|
||Property||||21,300|40,358|
||Bank interest||||5&020|228|
||Listed investments||||73,595|52,973|
||||||99,915|93,559|
##
##
|9
Total expendit|u|re
-group|||||||
|---|---|---|---|---|---|---|---|---|
||||||Commercial||||
||||Provision|Raising|trading|Support|2023|2022|
||||ofcare|funds|expenses|costsf|Total|Total
f.|
|Staffcosts|||5,666,771|305,932|1,886,158|30,716|7,889,577|7,549,239|
|Patient care|||104,604||||104,604|40,168|
|Medical supplies &drugs|||66,390||||66,390|69,926|
|Catering &domestic|supplies||71,616||||71,616|59,469|
|Travel expenses|||13,946||||13,946|11,804|
|Training &education|||50,997||309||51,306|52,449|
|Laundry|||16,281||||16,281|13,331|
|Electricity &Gas|||71,036||||71,036|44,013|
|Telephone|||43,111||||43,111|54,430|
|Rates and water|||3,472||||3,472|18,234|
|Uniforms|||6,689||||6,689|3,268|
|Printing,
Postage and|stationery||36,652||10,327||46,979|33,241|
|Insurance|||33,728||||33,728|37,488|
|Repairs and maintenance|||144,366||||144,366|119,846|
|Depreciation|||147,344||160,770||308,114|278,118|
|Direct fundraising
costs||||95,012|||95,012|46,242|
|Department
fundraising||costs||61,105|||61,105|56,953|
|Banking charges||||3,598|16,490||20,088|18,923|
|Administration
charge|||150,492|14,507|105,592||270,591|197,238|
|Audit and accountancy||||||18,058|18,058|15,302|
|Legal and professional||fees||||99,317|99,317|113,650|
|Irrecoverable
VAT||||11,940|||11,940|11,291|
|Cost ofsales|||||295,652||295,652|267,718|
|Shops operating
expenses|||||1,294,698||1,294,698|1,167,499|
|Investment
portfolio fees||||29,240|||29,240|28,009|
|Staffrelocation &recruitment|||||12,004||12,004|13,251|
||||6,627,495|521,334|3,782,000|148,091|11,078,920|10,321,100|
##
##
##
|charitable
|activity. Their d|et|ail along with basis o|fapportionment
is shown|in the table below:||
|---|---|---|---|---|---|---|
|||||Governance|Basis ofapportionment||
|||||function|||
|Staffcosts||||30,716|Key management
allocated on time||
|Audit and|accountancy|||18,058|Governance||
|Legal and|professional|||99,317|Governance||
|||||148,091|||
|Net income/(expenditure)|||for the year||||
|This is stated after charging|||the following:||||
||||||2023|2022|
|Auditors'|remuneration|—audit (group)|||18,058|15,302|
|Operating|leases||||722,782|697,340|
|Depreciation
(group)|||||308,114|278,118|
||2023|2022|
|---|---|---|
|Staff and management|259|249|
|The aggregate
payroll costs ofthese persons were as follows:|||
||2023|2022|
|||f.|
|Wages and salaries|6,785&031|6,450,178|
|Social security costs|616,019|566,357|
|Other pension costs|488,527|517,576|
|Termination
payments||15,128|
||7,889,577|7,549,239|
##
##
##
##
##
##
##
##
||||Cornwall|Cornwall|Resource|||
|---|---|---|---|---|---|---|---|
||||Hospice Care|Hospice Care|Kernow|||
||||Trading|Lottery|Newco|Total|Total|
||||Limited|Limited|Ltd|2023|2022|
||||f.|||||
|Per company accounts||||||||
|Turnover|||200,706|759,400||960,106|889,086|
|Cost ofsales|||(91,782)|(203,867)||(295,649)|(267,719)|
|Administrative|expenses||(50,374)|(120,356)||(170,730)|(162,534)|
|Interest receivable|||4,258|||4,258||
||||62,808|435,177||497,985|458,833|
|Amount
distributed||to the||||||
|charity via Gift|Aid||(44,287)|(350,447)||(394,734)|(474,652)|
|Result in the subsidiary|||18,521|84,730||103,251|(15,819)|
|The assets and liabilities ofthe subsidiaries
were||||||||
|||||Cornwall|Cornwall|Resource||
|||||Hospice Care|Hospice Care|Kernow||
|||||Trading|Lottery|Newco|Total|
|||||Limited|Limited|Ltd|2023|
|Per company accounts||||||||
|Fixed Assets|||||8,800||$,800|
|Current assets||||104,398|181,996||286,394|
|Current liabilities||||(41,586)|(105,618)||(147,204)|
|Total net assets||||62,812|85,178||147,990|
|Aggregate
share|capital and reserves|||62,812|85,178||147,990|
##
##
|The summary|financial performance ofthe charity alone is:|financial performance ofthe charity alone is:|financial performance ofthe charity alone is:|||
|---|---|---|---|---|---|
|||||Total|Total|
|||||2023|2022|
|Income||||11,627,374|10,494,817|
|Gift aid from subsidiaries||||394,734|474,652|
|||||12,022,108|10,969,469|
|Expenditure|on charitable||activities|10,932,142|9,949,240|
|Net income||||1,089,966|1,020,229|
|Total funds|brought|forward||10,045,268|9,025,039|
|Total funds|carried|forward||11,135,234|10,045,268|
|Represented|by:|||||
|Restricted funds||||740,860|729,329|
|Unrestricted|funds|||10,394,374|9,315,939|
|Total funds|carried|forward||11,135,234|10,045,268|
##
##
|Consolidated|||||||
|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|Total|
|||||funds|funds|2022|
|||||||g|
|Income|||||||
|Donations
8clegacies||||4,245,432||4,245,432|
|Income from Charitable|Activities|||l,060,463||1,060,463|
|Income from Other Trading|||Activities:||||
|Commercial
trading operations||||4,727,712||4,727,712|
|Fundraising||||585,128||585,128|
|Covid-19 support income||||143,450|192,023|335,473|
|Other income||||248,099||248,099|
|Investment
income||||93,559||93,559|
|Total Income||||11,103,843|192,023|11,295,866|
|Expenditure|||||||
|Expenditure
on raising|funds||||||
|Commercial
trading activities||||3,497,975||3,497,975|
|Costs ofgenerating
donations|||and legacies|391,124||391,124|
|Investment
portfolio fees||||28,009||28,009|
|Expenditure
on charitable||activities|||||
|Provision ofcare||||6,016,353|212,892|6,229,245|
|Supportcosts||||174,747||174,747|
|Total Expenditure||||10,108,208|212,892|10,321,100|
|Net gains on investments||||39,002||39,002|
|Net income/(expenditure)||||1,034,637|(20,869)|1,013,768|
|Other recognised
gains|and|losses|||||
|Gain on disposal offixed|assets||||||
|Loss on disposal ofinvestment|||property|(9,381)||(9,381)|
|Pension Liability|||||||
|Net movement
in funds||||1,025,256|(20,869)|1,004387|
|Reconciliation offunds:|||||||
|Fund balances brought
forward||||8,335,401|750,198|9,085,599|
|Fund balances carried forward||||9,360,657|729/29|10,089,986|
|||||||EVl|OO|||C
m|c||Vl
CO|||C&
QO||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||QO|||Oc|Vl
Vl|m
O||OI
Vl|||||
|||||||OO|||QO|||||||||
|||p|v
g
cd
8$ .~ o
9 M
O'g|||QO
C
CV|O||OO
Oc
Oc
Cl
m|Vl
OO
CV|Cd
C|||||Vl
OO(4|'0
QQ
0|
||||||||||||||||||0|
|||||VI|||||||Oc|||||||
||||O
o|I
.0||||||m
Vl|Cd||||||400|
||||C4|Pg||OO
Oc|||Oc
Oc
Cl|OIO
OI
&|OO
OI
m||||O|Oc
Vl
m|Cl0
Cl
O|
||||||||||||||||||I+l|
|||v
o
(n|'tl
Vo
cdo|O
O|ccl|Oc
C
O|Oc
IO
QO||Oc
OO|O
QO
Oc
OO|~
OO
O||O||Oc
Oc
CA
Oc|Oc
OO
O
OO|O
O
Cl|
|||||C48|||||||||||||0|
||||'tS
cd|cn
Cco
O|ccC||Oc
OO||Vl|m
OOO|Oc
O||O||Oc
co|OI
OO|00
+
cd|
|||||'tl||C=O|||QO||||||||'Cd|
||||O|||OO|||CV
OO|cV|~||m||OOrt|QO
Vl|g|
|CO|cd
C48||w|Pe||~A||||tV|||||||IO'03
O
g|
||||||||||||||||||Qll|
||I||||||||||||||||'0|
|~a
K,|cd'4
F4
cd|||||Cd O
OI
VI
ccl0
4ZZ5|||O
0|CIlO
«4|O
ID
OI
cd
OR0|||co
co|m|O
fV
0|'0
0j
'0
0
dl|
|||||||Cv)
m|O
O||||||||Oc|CI
CV||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||C||||OO
Vl|GO
O||||||
||||||||||OO||m|Cct||||||
|||||||GO|||OO||||||'ct|||
||||IA
I0
~4
A|dt
Cd
5
0
Cit||GO
pc|Cl
cct||||I/I
CV|C4
EA
M||OO|||'0
ID00
0|
||||||||||||||||||0|
||||W
oo.p|||GO
OO|I||||Cn|||O|Oc
Ch|O
GO
rn|cd
G
ID
IDpc
'00|
||||||||||||||||||0|
|||||||OO|hl||pc
pc||O0I||||00||0|
||||8
AI|'g
CA||0I|||pc
CI||pc||||CV||C&
CI|
|||o
Cit|ca
A
ID
g~|||CO|OO||OI
OO||CI
GO
pc
GO|GO
V1
O|||CO
OI
Oc
CC)
Oc|0I
OO
O
GO|CI
CV
CI
CV|
|||||0|||||||pc|||||||
|||||Ac8|||||||||||||0|
||||'lS
at
~
O|rn00
A
'0||0I
GO
O=O
OO|||||GO|pc
O||CI
ID|Oc
CO
OO|pc
OO
GO
it)|00
+ca0|
|||||||||||||||(V|||4|
||AI
o||Q|Fe|||||||||||||0
A|
||OD||||||||||||||||00|
||||||||||||||||||A0|
|+0|Cd"6
Gt
g
ID
00
A||||0t|CV
O
40I|W
0|0|O
CJ|.Cd
4
Ck|CV
O
't
0D|04
cp
Ott
cd|0
'0
C)
cd|CI|O
dt
4~
Cfj|CI
0|5
'0
0
'0
0|
||Cd|||||||'a||||ID
UX||||||
##
||Goodwill|Total|
|---|---|---|
|Cost or valuation|||
|At 1 April 2022|||
|Additions|||
|Disposals|||
|At 31March 2023|||
|Depreciation|||
|At I April 2022|||
|Charge for the year|||
|Released on disposal|||
|At 31March 2023|||
|Net book value|||
|At 31March 2023|||
|At 31March 2022|||
|21|Investments|Investments|||||||
|---|---|---|---|---|---|---|---|---|
||||Freehold|Investment|in||||
||||investment|subsidiary||Investment|Company|Group|
||||property|undertakings||portfolio|2023|2023|
||||||g||||
||At I April|2022|155,000|||4,662,563|4,817,568|4,817,563|
||Additions|at cost||||1,422,911|1,422,911|1,422,911|
||Disposals|||||(1,376,150)|(1,376,150)|(1,376,150)|
||Unrealised|losses||||(20,991)|(20,991)|(20,991)|
||Realised losses|||||(230,055)|(230,055)|(230,055)|
||At 31March 2023||155,000||5|4,458,278|4,613,283|4,613,278|
##
|22|Stocks|||||||
|---|---|---|---|---|---|---|---|
|||||Company|Group|Company|Group|
|||||2023|2023|2022|2022|
||Goods for resale|||3,470|76,809|12,079|87,377|
||Drugs, medical supplies etc.|||8,500|8,500|8,500|8,500|
||Maintenance|stocks||400|400|400|400|
|||||12,370|85,709|20,979|96,277|
|23|Debtors|||||||
|||||Company|Group|Company|Group|
|||||2023|2023|2022|2022|
||Gift Aid debtor|||95,765|95,765|89,607|89,607|
||VAT recoverable|||85,639|82,715|58,222|56,414|
||Amounts
owed by group undertakings|||||128,249||
||Other debtors|||19,079|19,079|59,400|59,381|
||Prepayments|and accrued income||262,584|274,681|412,168|416,893|
|||||463,067|472,240|747,646|622,295|
|24|Creditors:
amounts||falling due within one year|||||
|||||Company|Group|Company|Group|
|||||2023|2023|2022|2022|
||Trade creditors|||196,919|252,307|133,910|141,438|
||Other creditors|||69,806|68,830|70,186|69,179|
||Other taxation|and social security||135,813|136,698|129,967|130,705|
||Accruals|||429,358|451,188|278,312|314,743|
||Deferred income (note||25)|33,006|100,135|1,752|75,765|
||Amounts
owed|to group undertakings||148,582||||
|||||1,013,484|1,009,158|614,127|731,830|
##
##
##
||||CtI|m||||||Vl|O|O|rt|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||CtI
Vj|OO||m||||O|~
OO|||
||||m
CtI|Cl||Ch|||||||VlO|
||||Ch
OO|Vl
m
OO|OO
m|00
00
Ch
m||||CtI
t
m
mooo
LO
C
CO
Ch
OO
CtI||||
|||||O|'4t|||||||CtI|CtIrt|
||||||||I|||||||
|Ch4l
G
CC|I4,||Cl
ClO
ClOO||OOOOOO|OO
Cl|I
I
I
I
I
I
I
I|w
Cd|40|ClOO
O
Cl||OOO
OO|Cl
COO
CO
CO
t4|
||||||||I|||||||
||||||||I|||||||
|4l|||||Ch|Ch|Vl'0||||||Vl|
|||A|||Ch
LO|CtI
Vl|4l|g
V
gA||||V1
Cl|Vl|
||||||||C4|||||||
||||||||00|||||||
|Q|4l||Vl||O
Cl||A
I
I||||I|Cl||
|44|rn
Cl||m||||I
I
I|||||O||
||||||||I|||||||
||||||||I|||||||
|S4|||||||I
I|||||||
||||||||I|||||||
||||||||I|||||||
||||||||I|||||||
|44|||Ch|||40
Vl|I
I
I|44|A|||OO||
|AI I
U|||m|||'ct|I
I
I|C4I
V|||CV|||
|||||||M|I
I|||||||
||||||||I|||||||
||||||||I|||||||
||||||||||||||t4|
|||||||t4
Cl|||||||CO|
||||||||||||||Al|
||||O|||||||||||
||||||||OO|OO
OI
CO||Ch
Vl||C4
O|||||Q
'ct
Vl|Vl|I|Vl
IO
O|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||CI1||||||||O|||
||||||||OO|||OI|||||||OO|||Ch|
||||||||O|OO
OI
O|OO
Ch
O|OO|||||||IO
OI
O|IO
Vl
OI|OO
C4
O
C|OI
OI|
||||I||||||||I||||||||||
||||I
I
I
I
I
I|VI
ID
Cl|40
A||||OOO|CI
CI
CI
CI
CI|I
I
I
I
I
I||||||I|I|Q
CI
CI
O
Cl
CI|CIOOO
O|
||||I||||||||I||||||||||
||||I||||||||I||||||||||
||||'8||||||||'8||||||||||
||||A||||||||||||||||||
||||40
4J
CC
00|4k
O
8
4p
~M~||A||OO
Ch|O||CO
CC
00||||g44O
O
A
4|ccC|O
Yl|p)
CCI
M|O||
||||4||||||||4||||||||||
||||I||||||||I||||||||||
||||I
I
I|O
~m|4k||Vl|||VI|I
I
I|O|||||Vl||OO|CC
VI|
||||I
I
I
I
I|I|4l||CI||||I
I
I
I
I|C4
C4)||Ck4|||O
C||||
||||I||||||||I|CC|||||||||
||||I||||||||I||||||||||
||||I||||||||I||||||||||
||||I||||||||I||||||||||
||||I||||||||I||||||||||
||||I
I
I
I
III||||VI
VI
VI||||I
I
I
I
I
I|C4
AI
U|l|A|||ID
VI
IO
VI||Vl
CI|OI|
||||||||||||I||||||CI1||||
||P||||||||||I||||||||||
|||III|||||||||||||||||||
|||CC|88
O|||||~O
G||C4
CV|||||||cV|~OO4||C4
O
C4|
||~o|'C
CC|A||||CO|A||O|||||||~|4||O|
|m|5|C4
0|||||S4|5
B||m|||||||||||
|Q||U
00||||||GO|||||||||||||
##
##
##
##
|||Unrestricted|Restricted|Total|
|---|---|---|---|---|
|||funds|funds||
|Fixed assets
Investments
Current assets
Current
liabilities||3,404,050
4,613,278
3,534,194
(1,009,158)|740,860|4,144,910
4,613,278
3,534,194
(1,009,158)|
|||10,542,364|740,860|11,283,224|
|Consolidated
fund balances at 31 March 2022 are represented|by:||||
|||Unrestricted|Restricted|Total|
|||funds|funds||
|Fixed assets
Investments
Current
assets
Current
liabilities||3,446,691
4,817,563
1,828,233
(731,830)|729,329|4,176,020
4,817,563
1,828,233
(731,830)|
|||9,360,657|729,329|10,089,986|
##
##
##
|The total|amount ofother financial com|mitments
not provided
in the financial
state|mitments
not provided
in the financial
state|ments
was:|ments
was:|
|---|---|---|---|---|---|
|||Land &buildings||Land &buildings||
|||Company
2023|Group
2023|Company
2022|Group
2022|
|Expiring
Expiring
Expiring|within
1 year
2 - 5 years
in more than five years|787,311
2,722,453
2,476,841|787,311
2,722,453
2,476,841|450,928
1,321,130
508,798|450,928
1,321,130
508,798|
|||5,986,605|5,986,605|2,280,856|2,280,856|
|||Other||Other||
|||Company
2023|Group
2023|Company
2022|Group
2022|
|Expiring
Expiring|within
1 year
2-5 years|23,995
35,992|23,995
35,992|44,697
59,987|44,697
59,987|
|||59,987|59,987|104,684|104,684|
##
##
##
##
##
|||||||2023|2022|
|---|---|---|---|---|---|---|---|
|Net income/(expenditure)
per statement offinancial
Losses on investments
Investment
income
Add back loss on sale ofinvestment
property
Add back depreciation
charge
Decrease in stocks
Decrease in debtors
Increase in creditors||||activities||1,193,238
251,040
(99,915)
308,114
10,568
150,055
277,328|1,004,387
(39,002)
(93,559)
1,641
278,118
7,758
476,250
92,757|
|Net cash provided
by operating||activities||||2,090,428|1,728,350|
|Analysis ofnet debt||||||||
|||||1|April 2022|Cash flows|31March 2023|
|Cash at bank and in hand|||||1,109,661|1,866,584|2,976,245|